کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
4137952 | 1272115 | 2010 | 4 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Neoadyuvancia en cáncer de mama: Papel del patólogo
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
آسیبشناسی و فناوری پزشکی
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
Neoadjuvant therapy was first used for locally advanced breast carcinoma and in cases in which the carcinoma is initially inoperable. More recently, it has been extended to include operable, stage II/III carcinomas of the breast to increase the possibility of conservative surgery. Neoadjuvant therapy also allows the response of the primary tumour to a particular type of chemiotherapy to be evaluated and, if necessary, changed, in the absence of tumour response. Although the overall pathological response is a prognositic factor, no consensus has been reached as to the method of evaluation of this important pathological parameter and different criteria may be used in its assessment. Finally, core needle biopsy can provide important information which helps determine the indication for and the type of neoadjuvant therapy.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Revista Española de PatologÃa - Volume 43, Issue 2, AprilâJune 2010, Pages 90-93
Journal: Revista Española de PatologÃa - Volume 43, Issue 2, AprilâJune 2010, Pages 90-93
نویسندگان
Francisco Ignacio Aranda, Gloria Peiró, MarÃa Niveiro, Javier SeguÃ,